Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

Investegate announcements from BioNTech SE, Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

Related Keywords

Germany ,Qatar ,Gilboa ,Ha Afon ,Israel ,United States ,Canada ,United Kingdom ,Israeli ,Sylke Maas ,Fosun Pharma ,Emergency Department ,Emergency Department Admission ,Genentech ,Twitter ,United Kingdom Health Security Agency ,Bayer Animal Health ,Pfizer ,Pfizer Inc ,European Union ,Facebook ,Centers For Disease ,Drug Administration ,Exchange Commission ,Youtube ,Roche Group ,Israeli Ministry Of Health ,Large Us Health System ,Use Authorization ,Additional Booster Dose ,Older Adults ,Emergency Use Authorization ,Israeli Ministry ,Kaiser Permanente Southern California ,Marketing Authorization Holder ,Coronavirus Disease ,Disease Control ,Prescribing Information ,Breakthroughs That Change Patient ,Annual Report ,Looking Information ,Factors That May Affect Future ,New Technologies ,Private Securities Litigation Reform Act ,Year Ended December ,Dose Effectiveness ,Associated Emergency Department ,Urgent Care Encounters ,Hospitalizations Among Adults During Periods ,Omicron Variant Predominance ,Mortal Wkly ,Against Omicron Related Hospital ,Kingdom Health Security ,Efficacy Against Omicron ,Investegate Announcements ,Investegate Company Announcements ,Biontech Se ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,